Revive Biotechnology is a biotechnology company focusing on ophthalmic diagnostics. They are treating blinding retinal conditions with an oxygen encapsulated nanodelivery system, central retinal artery occlusion (CRAO). Founded in 2018, the company is working to improve the retina treatment and diagnostic modalities. Revive is a multidisciplinary, friendly, motivated, small team geared to excel. Their position at the University of Illinois Research Park allows them to use state-of-the-art laboratories and facilities to advance their company.